Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

CVKD Cadrenal Therapeutics

Watchlist
2.160
-0.090-4.00%
Close  02/07 16:00 ET
2.200
+0.040+1.85%
Post Mkt Price 02/07 17:38 ET
High
2.304
Open
2.200
Turnover
154.02K
Low
2.100
Pre Close
2.250
Volume
70.80K
Market Cap
25.13M
P/E(TTM)
0.00
52wk High
6.750
Shares
11.63M
P/E(Static)
0.00
52wk Low
2.100
Float Cap
3.02M
Bid/Ask %
0.00%
Historical High
6.750
Shs Float
1.40M
Volume Ratio
0.17
Historical Low
2.100
Dividend TTM
--
Div Yield TTM
--
P/B
-21.39
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
5.06%
Amplitude
9.05%
Avg Price
2.175
Lot Size
0
Float Cap
3.02M
Bid/Ask %
0.00%
Historical High
6.750
Shs Float
1.40M
Volume Ratio
0.17
Historical Low
2.100
Dividend TTM
--
P/B
-21.39
Dividend LFY
--
Turnover Ratio
5.06%
Amplitude
9.05%
Avg Price
2.175
Lot Size
0
Price Forecast

News

Comment

Company Overview More
Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focused on developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang Pham on January 25, 2022 and is headquartered in Ponte Vedra, FL.
CEO: Mr. Quang Pham
Market: NASDAQ
Listing Date: 01/20/2023
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist